Government Restricts Fixed-Dose Combinations with Two Compounds for Children Under Four
The government has restricted the manufacture, sale, and distribution of all fixed-dose combinations containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride, mandating a clear warning that these medicines should not be used in children under four years. This extends an earlier April 2025 notification targeting certain formulations. The decision, based on expert committee and Drugs Technical Advisory Board recommendations, cites potential risks to young children and availability of safer alternatives. Manufacturers must display the warning on labels, inserts, and promotional materials, effective immediately under the Drugs and Cosmetics Act.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (58/100). Lens Score 56/100.
Outlets measured: thehindu, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (62–72/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 22 Aug, 05:24 am. Other outlets followed.